Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosing regimens of celgosivir for the treatment of dengue

Dosing regimens of celgosivir for the treatment of dengue

US Patent 11219616 · Granted Jan 11, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for the treatment and prevention of lung infections caused by fungus by 2025
Rapid method of generating live attenuated vaccines2024
Regimens of tafenoquine for prevention of malaria in malaria-naïve subjects2023
Methods for the treatment and prevention of lung infections caused by gram-posit2023
Use of serotonergic drugs to treat virus-induced thrombocytopenia2022
Treatment of human coronavirus infections using alpha-glucosidase glycoprotein p2022
Antibodies that bind zika virus envelope protein and uses thereof2022
Antibodies that bind zika virus envelope protein and uses thereof2022
Antibodies that bind zika virus envelope protein and uses thereof2022
Dosing regimens of celgosivir for the prevention of dengue2021
Dosing regimens of celgosivir for the prevention of dengue2021
Dosing regimens of celgosivir for the prevention of dengue2021